Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2243 of 6351
-
Battle against superbugs: which antibiotic combo works best?
Disease control OngoingObjective of this study is to compare the efficacy and safety between combination of colistin and meropenem and combination of amikacin and meropenem for multi-drug-resistant gram-negative bacteria in Intensive Care Unit. In Beni- Suef University Hospital.
Phase 4 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Sound waves to soothe PTSD? new trial targets brain circuit in healthcare workers
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether low-intensity focused ultrasound (LIFU) of the ventral anterior cingulate cortex (vACC) can normalize dysfunctional brain activation patterns and behaviors in frontline healthcare workers with post-traumatic stress disorder. …
Sponsor: Laureate Institute for Brain Research, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Could cord blood transplants slow ALS? new trial begins
Disease control By invitation onlyAmyotrophic Lateral Sclerosis (ALS) is a rapidly progressive and fatal neurodegenerative disorder. Its global prevalence is approximately 0.73-1.89 per 100,000 individuals. In China, there are about 200,000 ALS patients, with approximately 25,000 new cases diagnosed annually. Mic…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Liver transplant drug showdown: which lowers pressure better?
Disease control Recruiting nowThe goal of this clinical trial is to compare the effects of somatostatin and terlipressin on lowering portal pressure in patients with portal hypertension undergoing liver transplantation, and to investigate whether there are differences in clinical outcomes between the two drug…
Sponsor: Istanbul Medipol University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Gene therapy injection aims to halt vision loss in stargardt patients
Disease control Recruiting nowTo evaluate the preliminary safety of monocular and single subretinal injection of ZVS106e injection in the treatment of patients with hereditary retinal degeneration (ABCA4-IRDS) caused by ABCA4 biallelic mutations.
Early phase 1 • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo therapy aims to restore hand function after stroke
Symptom relief Recruiting nowFollowing a stroke, the function of the distal upper limb, especially hand and finger movements, is often severely compromised, significantly restricting the ability to carry out daily activities. It is estimated that 55-75% of stroke survivors suffer from motor dysfunction, with…
Sponsor: King Saud University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Can video games keep your brain and body young? new study tests exergaming vs. traditional exercise
Symptom relief Recruiting nowThe primary aim of our study is to compare the effects of neuromuscular exercise training versus structured exergaming program on locomotor and cognitive functions in elderly individuals with Motor Cognitive Risk (MCR), which defines the transition state between typical aging and…
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New digital tool aims to curb antibiotic overuse in belgian Doctor's offices
Disease control Recruiting nowInappropriate antibiotic prescribing in primary care remains an important contributor to antimicrobial resistance. Despite the availability of evidence-based clinical guidelines, antibiotics are still frequently prescribed for self-limiting infections. Digital clinical decision s…
Sponsor: KU Leuven • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a common drug help cancer patients keep their appetite?
Symptom relief Recruiting nowThis phase II trial compares the effect of adding olanzapine to standard of care symptom management for nausea to standard of care alone in managing an abnormal loss of the appetite for food (anorexia) in patients treated with chemoradiation therapy (CRT) for head and neck cancer…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
New pill aims to tame manic episodes in bipolar disorder
Symptom relief Recruiting nowThe primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are currently experiencing an episode of mania with or without mixed features.
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer
Diagnosis Recruiting nowEvaluate the initial dose-effect and time-effect relationship of the injection product NC527-X
Phase 1 • Sponsor: Zhejiang Cancer Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
New therapy aims to help mothers in recovery connect with their kids
Symptom relief Recruiting nowMothers with substance use disorders face unprecedented stress in their roles as parents working to care for their children while maintaining healthy recovery. Mothering from the Inside Out (MIO) is the first attachment-based parenting intervention designed specifically for mothe…
Sponsor: Baystate Medical Center • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New pill shows promise in early trial for Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies. Anti-cancer therapy is a type of treatment to stop the growth of cancer. This study also aims to find the best amount of study m…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New rapid test could speed up UTI diagnosis and antibiotic choice
Diagnosis OngoingPerformance evaluation of QIAstat-Dx cUTI Plus AMR Panel using the QIAstat-Dx® Analyzer to demonstrate that the QIAstat-Dx cUTI Plus AMR Panel achieves its intended performance during normal conditions of use by the intended user in the intended environment
Sponsor: QIAGEN Gaithersburg, Inc • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
New eye drops aim to halt Vision-Threatening keratoconus
Disease control By invitation onlyThe goal of this clinical trial is to learn if TN-001, a new eye-drop therapy, is safe and well-tolerated in adult patients with progressive keratoconus. It will also provide data on whether this therapy is effective in treating keratoconus. The main questions it aims to answer …
Phase 1/2 • Sponsor: TheiaNova Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New nerve block could cut opioid use for liver donors
Symptom relief CompletedPostoperative pain control plays a crucial role in enhancing recovery and improving early mobilization in living liver donors. The rectus-intercostal fascial plane (RIFP) block is a novel ultrasound-guided regional anesthesia technique that provides anterior abdominal wall analge…
Sponsor: Istinye University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Kids' cough study: antibiotics or steroids – placebo may be just as good
Symptom relief Recruiting nowProlonged cough lasting more than four weeks is common in children, but the best treatment is often unclear when no underlying disease can be found. This study aims to find out whether commonly used treatments help children with prolonged cough more effectively than placebo. Chi…
Phase 3 • Sponsor: Tampere University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New combo aims to fix chemo side effect in cancer survivors
Disease control Recruiting nowThis is a prospective, randomized, open-label, active-controlled study to evaluate the efficacy and safety of Romiplostim N01 plus all-trans retinoic acid (ATRA) compared with Romiplostim N01 alone in adults with persistent isolated chemotherapy-induced thrombocytopenia (PICIT) a…
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Blood markers may spot deadly bowel condition before It's too late
Knowledge-focused Recruiting nowVascular bowel disease remains a socially significant and potentially fatal condition (if it develops into AMI), primarily due to delayed diagnosis. Blood biomarkers are theoretically ideal for early risk stratification (like troponins in myocardial infarction). However, the exis…
Sponsor: Belarusian State Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Gut-Brain connection in IBS: scientists hunt for clues to anxiety and depression
Knowledge-focused Recruiting nowThis study aims to understand how the gut and the brain communicate in people with Irritable Bowel Syndrome (IBS) who also experience anxiety and depression. We want to see if changes in gut bacteria are linked to changes in brain function, and to find potential markers that coul…
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC